James Brown Pharma
James Brown Pharma C.A. is an Ecuadorian pharmaceutical manufacturer founded in 1971 producing branded human and animal health products across two GMP-certified plants. The company serves domestic Ecuadorian markets through direct distribution and exports to six Latin American countries, specializing in softgel capsules, prefilled syringes, vaccines, and antiparasitics.
- Company typePrivate
- Founded1971
- HeadquartersQuito, Ecuador
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What James Brown Pharma does
James Brown Pharma C.A. is a privately held Ecuadorian pharmaceutical manufacturer founded in 1971 (originally as James Brown Productos Veterinarios) and headquartered in Quito, Ecuador. The company operates two specialized GMP-certified plants totaling more than 7,000 m² in Pifo (biologicals and human health) and Puembo (veterinary, operational since 1977), employing between 251 and 500 staff. It produces pharmaceutical and biological products across two primary lines: animal health (antibiotics, anti-inflammatories, antiparasitics, vaccines, vitamins, hormones for livestock, equine, and companion animals) and human health (softgel capsules, prefilled syringes, syrups, drops, and nutraceuticals across analgesics, anti-inflammatories, gastrointestinal, pediatric, gynecological, and neurological therapeutic areas).
The company's competitive positioning rests on technical first-mover advantages in Ecuadorian pharmaceutical manufacturing — it pioneered softgel capsule production nationally in 2009 and remains the only producer of single and double-chamber prefilled syringes in Ecuador since 2012. Manufacturing operates under Good Manufacturing Practices (BPM/INVIMA/DIGEMID/ARCSA/AGROCALIDAD/ISO 9001:2008) and includes classified clean rooms with real-time environmental monitoring and solar-powered facilities. James Brown Pharma serves customers through direct distribution in Ecuador and a network of regional distributors across six Latin American export markets (Bolivia, Peru, Panama, Guatemala, Costa Rica, Dominican Republic), with Bolivia identified as the strongest animal health export customer.
The business model combines branded pharmaceutical product sales (human and animal health lines), contract manufacturing (maquila) services for third-party pharma companies, and ancillary revenue from a MARS Andino exclusive distribution partnership for Pedigree and Whiskas pet food brands in Ecuador. The portfolio extends into adjacent operations including James Brown Genetics (bovine in vitro fertilization services), the Mascotas pet product line, and the Centro de Rescate JB wildlife rescue foundation. The company remains family-controlled under the Brown family lineage (founder James Brown Sweeney, current leadership Felipe Brown Hidalgo since 1993) with no external institutional investors, public listing, or disclosed funding rounds.
James Brown Pharma firmographics
Firmographics- Name
- James Brown Pharma
- Legal name
- James Brown Pharma C.A.
- Website
- https://jamesbrownpharma.com
- Company type
- Private
- Founded year
- 1971
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- James Brown Pharma C.A. is an Ecuadorian pharmaceutical manufacturer founded in 1971 producing branded human and animal health products across two GMP-certified plants. The company serves domestic Ecuadorian markets through direct distribution and exports to six Latin American countries, specializing in softgel capsules, prefilled syringes, vaccines, and antiparasitics.
- Ownership category
- akta.pro rank
James Brown Pharma industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)
- akta.pro secondary industries
- Specialty Care Pharmaceuticals (HLAIAAAB), Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ), Nephrology & Urology Specialty Pharmaceuticals (HLAIACAH), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)
Keywords
Where James Brown Pharma is headquartered
LocationHeadquarters
- HQ city
- Quito
- HQ country
- Ecuador
- HQ region
- Latin America
Offices5 records
Markets served
James Brown Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical Manufacturing and Sales: Manufacturing and commercialization of pharmaceutical and biological products for human and animal health lines. Products are sold domestically in Ecuador and exported to international markets including Bolivia, Peru, Panama, Guatemala, Costa Rica, and Dominican Republic.
- Contract Manufacturing (Maquila): Provides contract manufacturing services to other pharmaceutical companies using their production facilities and quality standards. Offers manufacturing of various products in different pharmaceutical forms for both human and veterinary markets.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
James Brown Pharma product offering
Product offeringCore offering
James Brown Pharma C.A. manufactures and commercializes pharmaceutical and biological products for two main lines: Human Health (analgesics, anti-inflammatories, gastrointestinal, pediatric, gynecological, neurological, and nutraceutical products in softgel capsules and pre-filled syringes) and Animal Health (antibiotics, anti-inflammatories, antiparasitics, vitamins, hormones, vaccines/biologicals, and pet care products). The company also provides contract manufacturing (maquila) services for other pharmaceutical companies using its GMP-certified facilities in Quito, Ecuador.
Product overview
James Brown Pharma is an Ecuadorian pharmaceutical company manufacturing and commercializing pharmaceutical and biological products for Animal Health and Human Health lines. The Human Health portfolio includes softgel capsules (SinDlor, PARACOLIC, Migraflash, Gripflash, LevoFlash, Lazarus, DigesGas Plus/250, TioRelax, TocoVit-E), pre-filled syringes (Neuroyecta 10,000 Plus, Neuroyecta 25,000 DC, Dexa Neuroyecta, Dolo-Neuroyecta DC, Ketol), pediatric formulations (Frizac, DigesGas Gotas, LevoFlash Kids, Vitamino), and nutraceuticals (PRIVU). The Animal Health portfolio spans antibiotics (Tilosina Tartrato, Enrobac, Fluvipen, Fortipen, Metrigen, Oxiter 200 L.A., Cefaspur, Polymast), anti-inflammatories (Flunixin, Flumezona, Benzapen L.A.), antiparasitics (Domax, Ivermec-JB, Ivequin, Eprinomax, Bendacur), vitamins and supplements (Amino-Vit, B-Plex, Ferro, Browni-Vit, Electravite, Calcifort, Fosfoplex, Fosforte), vaccines/biologicals (NEW-VAC, NEW+BRON, GUMBO-VAC, Tribac 8, Porci-Mix, Neumobac, Triviar), hormones (Celo Fijo, Post-Part), and pet care products (Meloxi-Flash, Garrakill, Ganador). The company also offers maquila (contract manufacturing) services for other pharmaceutical companies.
Differentiator
Problem solved
Functional benefit
Brands
- James Brown Genetics: Laboratorio de Fertilización In Vitro (FIV) para apoyo al mejoramiento genético ganadero del país
- Línea Mascotas
- Centro de Rescate JB
- Salud JB
- Jeringas Prellenadas
- Cápsulas Blandas
Products and services
- Softgel Capsules (Cápsulas Blandas) Softgel encapsulation platform used to produce multiple branded human and veterinary medications, providing superior bioavailability, precise dosing, and comfortable swallowing with oxygen- and moisture-resistant matrices; James Brown Pharma is the first laboratory in Ecuador to produce softgel capsules.
- Pre-filled Syringes (Jeringas Prellenadas / Hypack) Single and double-chamber pre-filled syringe dosage form platform guaranteeing dose precision, safety, and ease of use for human pharmaceutical applications including neuropathic pain and anti-inflammatory treatments; James Brown Pharma is the only producer of pre-filled syringes in Ecuador.
- Contract Manufacturing (Maquila) Services Contract manufacturing services offered to other pharmaceutical companies using James Brown Pharma's GMP-certified production facilities and ISO 9001:2008 quality systems. Capabilities span production of various products in different pharmaceutical forms for both human and veterinary markets.
- Human Health Pharmaceutical Product Line Branded human pharmaceutical products including analgesics and anti-inflammatories (SinDlor, Ketol, TioRelax), antipyretics/antispasmodics (PARACOLIC, Frizac), antimigraine (Migraflash), neuropathic pain pre-filled syringes (Neuroyecta 10,000 Plus, Dexa Neuroyecta, Dolo-Neuroyecta DC, Neuroyecta 25,000 DC), gastrointestinal (DigesGas Gotas, DigesGas Plus, DigesGas 250), antihistamines (LevoFlash, LevoFlash Kids), antigripal (Gripflash), supplements (TocoVit-E, Vitamino), erectile dysfunction (Lazarus), and natural nutraceuticals (PRIVU), sold in softgel, syrup, drops, powder, and pre-filled syringe formats.
- Animal Health Pharmaceutical Product Line (Pets / Mascotas) Pet care pharmaceutical products for dogs and cats including anti-inflammatories (Meloxi-Flash), wound healing treatments (Matagusanos Cura Heridas), vitamin supplements (Ganador, Amino-Vit Oral Mascotas), and antiparasitic sprays (Garrakill Can).
- Animal Health Pharmaceutical Product Line (Livestock - Antibiotics) Broad-spectrum antibiotic injectables and oral formulations for livestock including Tilosina Tartrato (poultry and swine), Fluvipen (penicillin + dihydrostreptomycin for mastitis/metritis/pneumonia across multiple species), Fortipen (penicillin/streptomycin/diclofenac), Metrigen (ceftiofur intrauterine), Oxiter 200 L.A., Cefaspur (ceftiofur), Polymast Azul/Rojo (intramammary for dairy cattle), Benzapen L.A., and Enrobac (enrofloxacin for poultry/dogs).
- Animal Health Pharmaceutical Product Line (Livestock - Antiparasitics) Endectocides and ectoparasiticides for livestock including Domax, Ivermec-JB, Ivequin (horses), Eprinomax (ruminants/rabbits/birds), Bendacur (oral suspension), Derribante (ectoparasiticide spray), and Garrakill.
- Animal Health Pharmaceutical Product Line (Livestock - Vaccines/Biologicals) Bacterin and biological vaccines including Porci-Mix (porcine septicemia), Tribac 8 (clostridial diseases in cattle/goats/sheep), Triviar (poultry cholera/typhoid/pullorosis), Neumobac (bovine respiratory), NEW-VAC (Newcastle disease), NEW+BRON (Newcastle + infectious bronchitis), and GUMBO-VAC (infectious bursal disease).
- Animal Health Pharmaceutical Product Line (Livestock - Vitamins/Supplements/Anti-inflammatories) Injectable and oral vitamin, mineral, electrolyte, and nutritional supplements (Amino-Vit Inyectable, Amino-Vit Oral, B-Plex, Ferro 100, Ferro 200, Calcifort, Fosfoplex, Fosforte, Browni-Vit, Electravite, Panadine), plus anti-inflammatory corticosteroids (Flumezona, Flunixin) and hormonal preparations (Celo Fijo, Post-Part).
- James Brown Genetics (In Vitro Fertilization Laboratory) In vitro fertilization (IVF) laboratory services for bovine genetic improvement in Ecuador, operating as a wholly-owned subsidiary of James Brown Pharma and applying advanced reproductive technologies to support cattle genetic quality and productivity.
Companies that use James Brown Pharma
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles5 records
James Brown Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
James Brown Pharma partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered major and core.
- MARS Andino de ColombiamajorStrategic alliance for Pedigree and Whiskas pet food brands. James Brown Pharma serves as importer for specialized and non-specialized channels, and exclusive distributor for specialized channel (Petshops, Veterinary Clinics, and Agropuntos).
- James Brown Productos Veterinarios de VenezuelacoreStrategic alliance established during Felipe Brown Hidalgo's management, expanding distribution channels to include Venezuela alongside existing Bolivia presence.
- Compañía Anchor (St. Joseph, Missouri, USA)coreOriginal partnership that led to founding the company. Anchor served as advisor and provided technical support for establishing pharmaceutical manufacturing operations in Ecuador. This relationship enabled James Brown to transition from distribution to local manufacturing of veterinary products.
Scale indicators4 records
Recent moves12 records
Expansion highlights6 records
James Brown Pharma competitors and assessment
Company assessmentBroad incumbents
- Virbac: Global animal health pharmaceutical company with significant exposure to Latin American livestock and companion animal markets. Competes with JB Pharma in parasiticides, anti-inflammatories, and reproductive health products for livestock and pets, with broader product breadth and stronger R&D pipeline.
- MSD Animal Health (Merck Animal Health): Global animal health division of Merck with comprehensive portfolio of parasiticides, vaccines, and therapeutics. Competes directly with JB Pharma across Latin American livestock markets, with significantly greater R&D firepower and access to proprietary molecules that JB Pharma does not have.
- Insud Pharma: Spanish-headquartered pharma group with deep Latin American operations across branded generics, animal health, and fine chemicals. Operates manufacturing across the region with GMP certifications similar to JB Pharma, and competes in overlapping therapeutic categories including OTC and specialty human pharma.
- Elanco Animal Health: Global animal health company offering parasiticides, vaccines, and therapeutic products for livestock and pets. Direct competitor to JB Pharma's livestock veterinary portfolio across Latin America, with significantly larger scale, broader pipeline, and stronger relationships with multinational distribution partners.
- Zoetis: Global leader in animal health pharmaceuticals and vaccines. Direct overlap with JB Pharma's livestock veterinary portfolio (parasiticides, antibiotics, vaccines) but at vastly greater scale; sets pricing and innovation benchmarks that constrain JB Pharma's animal health margins and competitive positioning across the Andean and Central American regions.
Direct peers
- Genfar: Colombian generic pharmaceutical manufacturer with regional LatAm presence (especially Andean markets). Comparable as a regional branded generic pharma manufacturer with INVIMA-certified manufacturing that competes head-to-head with JB Pharma's portfolio of analgesics, anti-inflammatories, GI, and antihistamine products across shared LatAm markets.
- Procaps: Colombian pharmaceutical manufacturer with proprietary softgel and sterile injectable capabilities, plus a meaningful animal health business (through its CAN unit). Direct overlap with JB Pharma's softgel and prefilled syringe technology positioning in Latin America and competing for similar INVIMA-registered distribution channels.
- Laboratorios Bago: Argentine pharmaceutical group with a comparable diversified portfolio spanning human health and animal health/veterinary products across Latin America. Similar multi-country Andean and Southern Cone distribution footprint, comparable GMP manufacturing footprint, and overlapping exposure to OTC generics and veterinary parasiticides — making it one of the closest regional analogues to James Brown Pharma's hybrid model.
Regional players
- Laboratorios Farmindustria: Peruvian pharmaceutical manufacturer with branded generic products sold domestically and exported regionally. Relevant because JB Pharma holds Peruvian DIGEMID certification and competes with Farmindustria in the Andean OTC/prescription generics market, particularly analgesics, anti-inflammatories, and respiratory products.
- Grupo Farma (Colombia): Colombian pharmaceutical group with branded generic manufacturing and regional export focus. Comparable as a mid-sized Andean pharma manufacturer competing for similar distribution partners and retail pharmacy channels in Colombia, Ecuador, and Peru.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
James Brown Pharma social profiles
Digital presenceJames Brown Pharma compliance and trust
Trust signalCompliance6 records
James Brown Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
James Brown Pharma leadership team
Management profileNumber of profiles
Profiles2 records
James Brown Pharma subsidiaries and ownership
Company hierarchySubsidiaries3 records
James Brown Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
James Brown Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about James Brown Pharma
What does James Brown Pharma do?
James Brown Pharma C.A. manufactures and commercializes pharmaceutical and biological products for two main lines: Human Health (analgesics, anti-inflammatories, gastrointestinal, pediatric, gynecological, neurological, and nutraceutical products in softgel capsules and pre-filled syringes) and Animal Health (antibiotics, anti-inflammatories, antiparasitics, vitamins, hormones, vaccines/biologicals, and pet care products). The company also provides contract manufacturing (maquila) services for other pharmaceutical companies using its GMP-certified facilities in Quito, Ecuador.
Is James Brown Pharma a public or private company?
James Brown Pharma is a private company. It is classified as family owned and is currently operating.
When was James Brown Pharma founded?
James Brown Pharma was founded in 1971. It employs 251 to 500 people.
Where is James Brown Pharma based?
James Brown Pharma is headquartered in Quito, Ecuador, in the Latin America region.
How does James Brown Pharma make money?
Two revenue lines are on record. Pharmaceutical Manufacturing and Sales are the primary driver. The others are contract Manufacturing (Maquila).
Who are James Brown Pharma's main competitors?
Broad incumbents on record are Virbac, MSD Animal Health (Merck Animal Health), Insud Pharma, Elanco Animal Health and Zoetis. Direct peers are Genfar, Procaps and Laboratorios Bago. Regional players are Laboratorios Farmindustria and Grupo Farma (Colombia).
Does James Brown Pharma have an API?
No public API is recorded for James Brown Pharma.
What industry is James Brown Pharma in?
James Brown Pharma's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAIAAAB, Specialty Care Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.